Amazon is reportedly mulling on expanding its business in Japan and entering the prescription drug market there. The e-commerce and tech firm is said to be planning to team up with small to mid-sized pharmacies for the project.
According to Nikkei Asia, some sources who are familiar with the project shared that Amazon may launch a new prescription service through partnerships with the local pharmacies in the Asian nation. They added that this is likely to be established starting next year when electronic prescriptions are set to be allowed in Japan for the first time.
The sources opined that if Amazon pushes through with this plan of jumping into the prescription drug sales business, this move could be a turning point for the local brick-and-mortar pharmacies in Japan.
This is because, with the application of Amazon’s cutting-edge ordering and distribution system, customers in the country will be able to have their medicines delivered right on the steps of their homes instead of going out to buy them in pharmacy stores.
To operate the business, Amazon will join forces with local pharmacies and set up a platform where patients can find instructions online - on how to take their medications. In any case, the prices of prescription drugs in Japan are usually set by the government, while the distribution system is in shambles since there are 70 wholesalers across the country, and the number of pharmacies has already reached 60,000.
Thus, if Amazon will enter the country’s prescription drug market, it will be able to offer a more organized distribution system as well. This means that patients and consumers will be able to receive their medicines in a timely and orderly manner.
Meanwhile, Fox Business further reported that the new prescription service may be launched next year and through Amazon, pharmacies in Japan will be able to sell medicines directly to patients online since Japan will start allowing electronic prescriptions in the country by that time. People may obtain virtual prescriptions on Amazon’s platform after receiving professional medical care online.


Wistron Opens $700M Texas AI Factory to Build Nvidia Superchips in U.S.
Judge Approves Anthropic’s $1.5 Billion AI Copyright Settlement With Authors
Morgan Stanley Downgrades Adobe, Workday as AI Transition Raises Growth Concerns
European Stocks Slip as Earnings, UK Inflation and ECB Decision Keep Investors on Edge
Belimo H1 Sales Surge as AI Data Center Cooling Drives More Than Half of Growth
Australia ASIC Tightens Auditor Oversight After KPMG Leak Scandal
Nasdaq Drops as AI Earnings, Oil Surge and Middle East Tensions Weigh on Wall Street
Asian Currencies Hold Steady as Middle East Tensions Boost US Dollar, Oil Concerns
Japan Yen Slides Past 163 as Middle East Tensions Lift US Dollar, Oil Prices
US Dollar Pauses Rally as Middle East Tensions Support Safe-Haven Demand
Samsung Cuts U.S. Consumer Electronics Jobs as Headquarters Moves to Texas
Nvidia Reveals 9.3% Stake in AI Cloud Firm Nebius Following $2 Billion Investment
Alphabet Q2 Earnings Beat Estimates as AI Spending, Google Cloud Growth Fuel Outlook
US Dollar Climbs to Weekly High as Middle East Tensions Lift Treasury Yields and Safe-Haven Demand
Gold Price Jumps Near 2% Above $4,080 as Middle East Tensions Lift Safe-Haven Demand
US Stock Futures Rise as AI Optimism Lifts Tech, 3M Jumps on Strong Earnings
GE Vernova Q2 Revenue Tops Estimates as Earnings Miss, Shares Slide Despite Higher 2026 Outlook 



